Active14544942Private limited companyOxford

ISOGENIX LIMITED

Significant control: Oxford Science Enterprises PLC (50–75%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Isogenix Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Isogenix Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

ISOGENIX LIMITED is an active private limited company (company number 14544942) incorporated on 16 December 2022, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £885k and cash of £752k, with 4 employees on average. Net assets fell 62% on the prior period (£2.31m). Across the last 3 periods on record the net-asset trend is falling.

Peer position · net assets

By net assets it sits in the top quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).

02

Ownership and control

1 active · 2 other
  • Oxford Science Enterprises Plc
    corporate entity, England And Wales · since 6 April 2023
    • owns 50–75% of shares
    • holds 50–75% of voting rights
    • can appoint or remove directors
  • Prof Matthew John Andrew Wood
    Individual · since 16 December 2022 · ceased 6 April 2023
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Carlo Rinaldi
    Individual · since 16 December 2022 · ceased 6 April 2023
    • owns 25–50% of shares
    • holds 25–50% of voting rights

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
16 December 20223 yrs ago
Next accounts due
30 September 2027in 341 days
Confirmation statement due
30 December 2026in 67 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

3 periods on record · latest ending 31 December 2025
Net assets
£885k
−62%vs Dec 2024
Cash at bank
£752k
−65%vs Dec 2024
Turnover
Not reported
Employees
4
No changevs Dec 2024
Net assets
£885k
Cash at bank
£752k
Average employees
4
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2025£885k£752k£18k£80k——4
31 December 2024£2.31m£2.16m£251k£187k——4
31 December 2023£3.39m£3.13m£209k£86k——1
Current ratio9.65Current assets ÷ creditors within one year
Cash per employee£188kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £884,975 at 31 December 2025
  • Net assets down 25% or more on the prior period-61.8% vs prior period
  • Current assets at least 1.5× creditors within one yearCurrent ratio 9.65
  • Cash at bank of £50,000 or moreCash £752,266
  • Three or more accounting periods on record3 periods on record
  • Incorporated two to five years agoIncorporated 16 December 2022

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 341 days
  2. Confirmation statement duein 67 days
  3. Accounts period endNet assets £885k · small accounts
  4. Accounts period endNet assets £2.31m · small accounts
  5. Accounts period endNet assets £3.39m · small accounts
  6. Incorporated
08

Similar companies in Oxford

Same activity (research and experimental development on biotechnology), closest in incorporation date
09

Reminders for ISOGENIX LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.